RYE BROOK, N.Y.–(BUSINESS WIRE)–International technology group SCHOTT, a leader in high-performance materials and optics, has achieved a breakthrough in high-volume production of Geometric Reflective Waveguides. This marks a key advancement for Augme…
Category: News
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter financial results on Wednesday, Oct. 29, 2025. The …
Key Predictors of Long-Term Outcomes in Childhood Glaucoma
Measuring visual acuity and intraocular pressure at 5 years after diagnosis, and checking for conditions such as nystagmus and angle closure, can predict long-term outcomes in pediatric glaucoma. Medscape Medical News
Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today celebrated the …
Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) today announced that …
Can Metformin Protect Against Macular Degeneration?
Use of metformin does not appear to be associated with the development or progression of age-related macular degeneration, a study finds. Medscape Medical News
Horizon Surgical Systems Appoints Rajesh K. Rajpal, MD as Chief Strategy and Medical Officer
SANTA MONICA, Calif.–(BUSINESS WIRE)–Horizon Surgical Systems, a leader in surgical robotic platforms, appoints Rajesh K. Rajpal, MD as its Chief Strategy and Medical Officer (CSO & CMO).
Racial Differences Found in Dupilumab Side-Effect Profiles
A retrospective chart review finds that Black patients with atopic dermatitis report fewer dupilumab-associated adverse events than White patients. Medscape Medical News
Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon
HONG KONG–(BUSINESS WIRE)–Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR”) (NASDAQ:STAA), today announced its opposi…
Gene Therapy Shows Signal for Improving Retinal Function
Patients with potentially blinding retinitis pigmentosa recover retinal sensitivity 3 years after receiving a gene therapy targeting the causal mutation. Medscape Medical News
Glaucoma Linked to Increased Risk for Dementia
Glaucoma is linked to an increased risk for dementia, with the strength of the association depending on the forms of glaucoma and dementia and the APOE genotype, according to a retrospective study. Medscape Medical News
Aflibercept 8 mg Shows Gains in Previously Untreated AMD
Patients with age-related macular degeneration who are new to treatment experience gains in vision and anatomical markers 6 months after starting high-dose aflibercept, a study shows. Medscape Medical News
iVeena Awarded $2 Million National Eye Institute Grant to Advance Novel Therapy for Pediatric Myopia
SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology company, today announced it has been awarded a $2 million Phase 2 Small Business Innovation Research (SBIR) grant from the National Eye Institute …
Preservative-Free Eye Gel Matches Standard Glaucoma Care
Preservative-free bimatoprost gel is noninferior to the preserved form of the drug solution for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, a study finds. Medscape Medical News
Preservative-Free Eye Gel Matches Standard Glaucoma Care
Preservative-free bimatoprost gel is noninferior to the preserved form of the drug solution for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, a study finds. Medscape Medical News
Study Supports Earlier Start for Geographic Atrophy Drug
Patients who start on pegcetacoplan for geographic atrophy at the outset of a 4-year study retain almost three times more macular tissue than those who wait to begin treatment. Medscape Medical News
Le Symposium 2025 sur les nouvelles technologies de la vision périphérique rétinienne et la première conférence clinico-universitaire VPR se sont conclus avec un grand succès.
PÉKIN–(BUSINESS WIRE)–Le 3 septembre 2025, le « Symposium 2025 sur les nouvelles technologies de la vision périphérique rétinienne et la première conférence d’échange clinico-universitaire sur la VPR » s’est tenu à Hangzhou Chine. Organisé par Beijin…
iCare Launches ALTIUS: The Game-Changing Cloud Platform Redefining Eye Care Imaging
RALEIGH, N.C.–(BUSINESS WIRE)–iCare USA, a global innovator in eye care diagnostics, proudly unveils the launch of iCare ALTIUS™, a sleek cloud platform that’s set to disrupt how eye care professionals capture, manage, and share diagnostic images. Bu…
AREDS Vitamins Show No Effect in Geographic Atrophy
An analysis of pivotal phase 3 trials shows supplements to arrest age-related macular degeneration have no effect on geographic atrophy. Medscape Medical News
Eye Surgery Follow-Ups: Does a Day Make a Difference?
Follow-up visits on the day of surgery may offer patients greater flexibility without sacrificing safety, a study shows. Medscape Medical News